56 results on '"Miras M"'
Search Results
2. Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study
3. Patients With Terminal Chronic Liver Pathology Faced With This Disease
4. The Evolution of Therapeutic Strategies for Biliary Tract Complications After Liver Transplantation Over a Period of 20 Years
5. Emotional-Type Psychopathologic Symptoms among Patients with Terminal Chronic Alcohol-Induced Liver Cirrhosis
6. Laparoscopic Treatment of Biliary Peritonitis after Removal of T-Tube in Liver Transplant Patients
7. Development and Validation of a Specific Questionnaire for Evaluating the Impact of Gastrointestinal Symptoms on the Health-Related Quality of Life of Transplant Patients
8. Evolution of soluble forms of CD86, CD95 and CD95L molecules in liver transplant recipients
9. Value of 18-FDG-Positron Emission Tomography/Computed Tomography Before and After Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation: Initial Results
10. CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation
11. Divergences in KIR2D + natural killer and KIR2D +CD8 + T-cell reconstitution following liver transplantation
12. Transhepatic Portal Venous Angioplasty With Stenting for Bleeding Jejunal Angiodysplasias in a Retrasplant Patient: A Case Report
13. Psychological Care: Social and Family Support for Patients Awaiting a Liver Transplant
14. Results of Liver Transplantation from Donors Over 75 Years: Case Control Study
15. Psychological Characteristics of Patients on the Liver Transplantation Waiting List With Depressive Symptoms
16. Coping Styles of Patients on the Liver Transplant Waiting List
17. Improving the Waiting List by Using 75-Year-Old Donors for Recipients With Hepatocellular Carcinoma
18. Importance of Introduction of a Psychological Care Unit in a Liver Transplantation Unit
19. Activated Regulatory T Cells Expressing CD4+CD25highCD45RO+CD62L+ Biomarkers Could Be a Risk Factor in Liver Allograft Rejection
20. Clinical Evolution in the First 3 Months of Patients After Liver Transplantation in Maintenance Phase Converted From Mycophenolate Mofetil to Mycophenolate Sodium Due to Gastrointestinal Complications
21. Gastrointestinal Complications in Liver Transplant Recipients: MITOS Study
22. Evaluation of CD86 gene polymorphism at + 1057 position in liver transplant recipients
23. Central Pontine and Extrapontine Myelinolysis: A Rare and Fatal Complication after Liver Transplantation
24. Copper metabolism and biliary secretion in patients receiving orthotopic liver transplantation
25. Recurrence of alcoholism and quality of life in patients with alcoholic cirrhosis following liver transplantation
26. HLA class I expression on peripheral blood lymphocytes and hepatocytes after liver transplantation
27. Role of Liver Transplantation in the Management of Unresectable Neuroendocrine Liver Metastases
28. DQA1 and DQB1 genes polymorphism on acute rejection development in liver transplantation
29. Reversibility of the neurologic alterations in familial amyloidotic polyneuropathy type I after liver transplantation (22 cases)
30. Sequential (domino) liver transplantation in familial amyloidotic polyneuropathy type II
31. Recipient factors analysis in long-term allograft survival of liver transplantation
32. Prognostic factors of early acute renal failure in liver transplantation
33. Could expression of co-stimulatory molecules on B-PBL condition the acceptance or rejection of human liver grafts?
34. Long-term results of liver transplantation in four siblings from the same family with familial amyloidotic polyneuropathy type I TTR ALA-71
35. Incidence and management of biliary tract complications following 300 consecutive orthotopic liver transplants
36. P908 EVEROLIMUS TREATMENT IN LIVER TRANSPLANTATION ACCORDING TO CLINICAL PRACTICE: A SPANISH MULTICENTRE COHORT
37. Association between bone mineral density and VDR and IGF-1 gene polymorphisms in patients with congenital adrenal hyperplasia treated with glucocorticoids
38. Osteocalcin determination in children with growth hormone deficiency using two commercial immunoassays: Electrochemiluminescence (ECLIA) and chemiluminescence (CLIA) assays
39. Clinical, molecular and bone metabolism studies in patients with Congenital Adrenal Hyperplasia
40. Polymorphisms of 3′ extreme of VDR gene in Turner syndrome
41. Polymorphisms of genes associated to bone mineral density in small for gestational age children
42. Methylenetetrahydrofolate reductase and vitamin D receptor genotypes in turner syndrome patients
43. Bone mineral density and biochemical variables of the IGF system in small for gestational age children
44. 129 The five year follow-up of a randomized study comparing lamivudine with lamivudine+HBIG investigating the prevention of HBV recurrence after liver transplantation
45. 422 Efficacy and safety of adefovir for the treatment of patients with chronic hepatitis B (CHB) resistant to lamivudine in Spain
46. Impact of the hepatitis C virus on the acute rejection rate in kidney transplant patients
47. Prolonged follow-up of HBV liver transplanted patients: results from a randomized study comparing lamivudine vs. lamivudine+HBIG in the prevention of HBV recurrence after liver transplantation
48. Adiposity in adult growth hormone deficiency:prediction factor of growth hormone replacement dosage?
49. One month of lamivuidine plus HBIg followed by lamivudine vs lamivudine + HBIg in the prevention of HBV recurrence after liver transplant
50. Childhood- and adult-onset growth hormonedeficiency: Differences in cardiac function patterns in adults
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.